
OraSure Technologies, Inc. develops and markets diagnostic products and medical devices for HIV and drug testing.
OraSure Technologies, Inc., founded in 1987, is a medical device company focused on developing, manufacturing, and marketing diagnostic products and medical devices. The company's core mission is to provide innovative solutions for disease diagnosis and patient care, with a vision of improving global health outcomes. OraSure offers a range of products, including oral fluid collection devices and assays for HIV antibody detection and drugs-of-abuse testing. Their market focus spans the life insurance industry, public health sectors, and broader healthcare markets.
Notable affiliated individuals include key scientists and healthcare professionals who contribute to the company's research and development efforts. OraSure has received investments from prominent healthcare and technology investors, bolstering its growth and innovation capabilities. Key achievements include the widespread adoption of their HIV testing products and significant contributions to public health diagnostics. OraSure's impact is evident in its role in enhancing disease detection and linking patients to precise care, thereby improving health outcomes globally.
Companies similar to OraSure Technologies include QuidelOrtho, Orion, PointCare Technologies and Trinity Biotech.
OraSure Technologies was founded in 1987.
OraSure Technologies' headquarters is located in Bethlehem, PA, US.
OraSure Technologies' most recent funding round was for $10.4M (USD) in October 2022.
As of Oct 2, 2022, OraSure Technologies has disclosed funding of $136M (USD). Undisclosed round amounts are excluded.
OraSure Technologies has 840 employees as of Feb 6, 2024.
Trinity Biotech
trinitybiotech.com